Skip to content

800.850.4306

  • About Us
    • Who We Are
    • Leadership
    • Accreditations
    • Careers
  • Insights
    • News
    • Our Stories
    • Events
  • Contact Us
  • About Us
    • Who We Are
    • Leadership
    • Accreditations
    • Careers
  • Insights
    • News
    • Our Stories
    • Events
  • Contact Us
  • Patients
    • Oncology
    • Rare and Orphan Care
    • Cell and Gene Therapy
    • Financial Assistance
    • Frequently Asked Questions
  • Providers
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Payers
  • How to Prescribe
    • Specialty Drugs List
  • Patients
    • Oncology
    • Rare and Orphan Care
    • Cell and Gene Therapy
    • Financial Assistance
    • Frequently Asked Questions
  • Providers
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Biopharma
    • Oncology
    • Rare and Orphan Care
    • Risk-Based Care
    • Cell and Gene Therapy
  • Payers
  • How to Prescribe
    • Specialty Drugs List

Tag: AML

VANFLYTA (quizartinib), FDA Approved in the U.S. for Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia, Available at Biologics by McKesson

Biologics by McKesson is a specialty pharmacy provider for VANFLYTATM (quizartinib)

CARY, N.C., Aug. 4, 2023 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was […]

REZLIDHIA (olutasidenib), FDA-Approved for Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia, Available at Biologics by McKesson

CARY, N.C., Dec. 19, 2022—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

11800 Weston Parkway
Cary, NC 27513
T. 800.850.4306

Legal

  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice
  • Privacy Notice
  • Terms of Use
  • Nondiscrimination Notice
  • Change Healthcare HIPAA Substitute Notice

For Patients

  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)
  • Privacy Practices (PDF)
  • Patient’s Rights (PDF)

Learn more about McKesson

  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe
  • Home
  • Patients
  • Providers
  • Payers
  • Biopharma
  • News
  • Careers
  • About Us
  • Contact
  • Resources
  • How to Prescribe

© 2025 McKesson Corporation. All Rights Reserved.